Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P.308 A double-blind, randomized, placebo-controlled phase 3 study of sage-217 in postpartum depression: improvements in unidimensional measures of depression and anxiety

Autor: R. Lasser, K. Deligiannidis, H. Gunduz-Bruce, C. Silber, A. Sankoh, S. Li, J. Jonas, J. Doherty, S. Kanes

Publikováno v: European Neuropsychopharmacology. 29:S219-S220

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9209b06b7a516c4b294d5d0e27b9880
https://doi.org/10.1016/j.euroneuro.2019.09.328

Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women

Autor: Nancy T. Field, Louise C. Laurent, Nelson C. Echebiri, Lanissa M. Pappas, Aisling Murphy, Mary E. Norton, Deborah A. Wing, Sina Haeri, Angelle A. Brebnor, Angela C. Silber, John D. Yeast, Cheryl K. Roth, Carl P. Weiner, Albert Franco, J. Gerald Quirk

Publikováno v: Obstetrics and gynecology, vol 130, iss 6
Wing, Deborah A; Haeri, Sina; Silber, Angela C; Roth, Cheryl K; Weiner, Carl P; Echebiri, Nelson C; et al.(2017). Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women.. Obstetrics and gynecology, 130(6), 1183-1191. doi: 10.1097/aog.0000000000002367. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/90j3j9n5

ObjectiveTo compare the rapid bedside test for placental α microglobulin-1 with the instrumented fetal fibronectin test for prediction of imminent spontaneous preterm delivery among women with symptoms of preterm labor.MethodsWe conducted a prospect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4566117c44289538d2b5fd7aaa1b084e
https://escholarship.org/uc/item/90j3j9n5

Product Switching in the Pharmaceutical Industry: Ripe for Antitrust Scrutiny?

Autor: Seth C. Silber, Kara Kuritz

Publikováno v: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 7:119-130

Since the Hatch-Waxman Act was enacted in 1984, generic drug companies have benefited from its provisions to facilitate approval of generic alternatives to brand-name pharmaceuticals. Upon generic entry, consumers of prescription drugs benefit from l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cd5f93426b057ea57d3a3fc963986dd8
https://doi.org/10.1057/jgm.2010.1